Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Rosuvastatin 10 mg vs Crestor in Healthy Volunteers
NCT05197517Phase 1Completed
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin in hypercholesterolemia (2 arms). Primary endpoints: Maximum Plasma Concentration at 72 hours, Area Under the Plasma Concentration Curve from Administration to Last Observed Concentration at 72 hours and 1 more. Started Sep 2020; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT05197517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05197517.